Human insulin is used to regulate glucose metabolism in the human
body. It also helps in regulating carbohydrate and fat metabolism in
people with diabetes. With the growing incidence of diabetes across the globe,
insulin is a much needed glucose regulating method for the patients.
Reports and Intelligence adds a report titled “Global Human
Insulin Market (Product Type, Brand and Geography) - Size, Share, Global
Trends, Company Profiles, Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 – 2020.” The report states that
the global human insulin market is expected to witness a significant growth
rate during the forecast period.
Get access to detailed report at: http://www.reportsandintelligence.com/human-insulin-market
The report examines the global market through various segments
such as types, brands, technologies, geographies and competitive landscape. It
also provides deep insights of the global market by analyzing market trends and
various factors influencing the growth of the market.
The growing number of obesity cases, changing lifestyle, geriatric
population and inadequate healthcare conditions in many regions are leading to
the growth of diabetes. The growing number of diabetic patients is fuelling the
growth of the global human insulin market. Also, technological advancements
such as insulin pens and many more coming up would propel the growth of the
global market.
The report segment on the product type mainly includes modern and
traditional types of human insulin. Traditional human insulin segment consists
of Intermediate Acting, Premixed and Short Acting types of Human Insulin.
Modern human insulin types includes Long Acting, Rapid Acting Premixed types of
human insulin. The efficiency of the modern human insulin is making it a
preferred choice by the end users. Long acting and premixed modern insulin are
the main types of human insulin that are expected to grow rapidly during the
forecast period.
As per the report, Asia-Pacific and LAMEA are the fastest growing
geographical regions with large number of diabetic patients, improving
healthcare conditions and favorable government regulations. Other
geographical regions included in the report are North America and Europe, out
of which North America would dominate the global human insulin market in terms
of revenue.
The report would provide the market investors with comprehensive
knowledge of the global market and competitive scenario at the global level. It
provides extensive information of the developmental strategies adopted by the
global players and technological advancements in the field of human insulin
market.
Report profiles the following companies from the global
market:
Eli Lilly
GlaxoSmithCline
Biocon
Sanofi
Aventis
Julphar
Novo Nordisk
SemBioSys
Wockhardt
